Patents by Inventor Daisuke Honma
Daisuke Honma has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11915778Abstract: A semiconductor memory device includes: a core unit including first and second memory cell groups; and a control circuit. The control circuit is configured to, in response to a read command including designation of a first address and designation of a second address, read first data from the first memory cell group, read second data from the second memory cell group, and output third data and fourth data in parallel. The first and second addresses correspond to the first and second memory cell groups, respectively. The designation of the second address is made after the designation of the first address. The third data corresponds to the read first data. The fourth data corresponds to the read second data.Type: GrantFiled: March 15, 2022Date of Patent: February 27, 2024Assignee: Kioxia CorporationInventors: Daisuke Arizono, Akio Sugahara, Mitsuhiro Abe, Mitsuaki Honma
-
Publication number: 20210393601Abstract: An object of the present invention is to provide a combination drug having an EZH1/2 dual inhibitor in combination with another medical agent and exerting an excellent anticancer effect. Provided is a combination drug having an EZH1/2 dual inhibitor in combination with another medical agent and exerting an excellent anticancer effect.Type: ApplicationFiled: November 29, 2019Publication date: December 23, 2021Applicant: DAIICHI SANKYO COMPANY, LIMITEDInventor: Daisuke HONMA
-
Patent number: 10954219Abstract: The present invention provides a compound having a particular chemical structure or a pharmacologically acceptable salt thereof which has an excellent inhibitory effect on EZH1 and/or EZH2 activity. The present invention provides a compound having a 1, 3-benzodioxole structure represented by the general formula (I) or a pharmacologically acceptable salt thereof, or a pharmaceutical composition comprising the compound (wherein R1, R2, R3, R4, R5, R6, and V in the formula (I) are each as defined in the present specification).Type: GrantFiled: June 7, 2018Date of Patent: March 23, 2021Assignee: DAIICHI SANKYO COMPANY, LIMITEDInventors: Osamu Kanno, Jun Watanabe, Takao Horiuchi, Akira Nakao, Keisuke Suzuki, Tomonori Yamasaki, Nobuaki Adachi, Daisuke Honma, Yoshito Hamada
-
Patent number: 10434091Abstract: The present invention provides an agent for treating and/or preventing adult T cell leukemia/lymphoma containing a compound having a specific chemical structure or a pharmaceutically acceptable salt thereof. Specifically, the present invention provides an agent for treating and/or preventing adult T cell leukemia/lymphoma containing, as an active ingredient, 7-chloro-2-[trans-4-(dimethylamino)cyclohexyl]-N-[(4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-2,4-dimethyl-1,3-benzodioxole-5-carboxamide or a pharmaceutically acceptable salt thereof, or 7-bromo-2-[trans-4-(dimethylamino)cyclohexyl]-N-[(4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-2,4-dimethyl-1,3-benzodioxole-5-carboxamide or a pharmaceutically acceptable salt thereof.Type: GrantFiled: July 29, 2016Date of Patent: October 8, 2019Assignees: DAIICHI SANKYO COMPANY, LIMITED, THE UNIVERSITY OF TOKYOInventors: Toshiki Watanabe, Makoto Yamagishi, Osamu Kanno, Jun Watanabe, Nobuaki Adachi, Daisuke Honma, Yoshito Hamada
-
Publication number: 20180282313Abstract: The present invention provides a compound having a particular chemical structure or a pharmacologically acceptable salt thereof which has an excellent inhibitory effect on EZH1 and/or EZH2 activity. The present invention provides a compound having a 1,3-benzodioxole structure represented by the general formula (I) or a pharmacologically acceptable salt thereof, or a pharmaceutical composition comprising the compound (wherein R1, R2, R3, R4, R5, R6, and V in the formula (I) are each as defined in the present specification).Type: ApplicationFiled: June 7, 2018Publication date: October 4, 2018Applicant: DAIICHI SANKYO COMPANY, LIMITEDInventors: Osamu KANNO, Jun WATANABE, Takao HORIUCHI, Akira NAKAO, Keisuke SUZUKI, Tomonori YAMASAKI, Nobuaki ADACHI, Daisuke HONMA, Yoshito HAMADA
-
Publication number: 20180200238Abstract: The present invention provides an agent for treating and/or preventing adult T cell leukemia/lymphoma containing a compound having a specific chemical structure or a pharmaceutically acceptable salt thereof. Specifically, the present invention provides an agent for treating and/or preventing adult T cell leukemia/lymphoma containing, as an active ingredient, 7-chloro-2-[trans-4-(dimethylamino)cyclohexyl]-N-[(4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-2,4-dimethyl-1,3-benzodioxole-5-carboxamide or a pharmaceutically acceptable salt thereof, or 7-bromo-2-[trans-4-(dimethylamino)cyclohexyl]-N-[(4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-2,4-dimethyl-1,3-benzodioxole-5-carboxamide or a pharmaceutically acceptable salt thereof.Type: ApplicationFiled: July 29, 2016Publication date: July 19, 2018Applicants: DAIICHI SANKYO COMPANY, LIMITED, THE UNIVERSITY OF TOKYOInventors: Toshiki WATANABE, Makoto YAMAGISHI, Osamu KANNO, Jun WATANABE, Nobuaki ADACHI, Daisuke HONMA, Yoshito HAMADA
-
Patent number: 10017500Abstract: The present invention provides a compound having a particular chemical structure or a pharmacologically acceptable salt thereof which has an excellent inhibitory effect on EZH1 and/or EZH2 activity. The present invention provides a compound having a 1,3-benzodioxole structure represented by the general formula (I) or a pharmacologically acceptable salt thereof, or a pharmaceutical composition comprising the compound (wherein R1, R2, R3, R4, R5, R6, and V in the formula (I) are each as defined in the present specification).Type: GrantFiled: March 16, 2015Date of Patent: July 10, 2018Assignee: DAIICHI SANKYO COMPANY, LIMITEDInventors: Osamu Kanno, Jun Watanabe, Takao Horiuchi, Akira Nakao, Keisuke Suzuki, Tomonori Yamasaki, Nobuaki Adachi, Daisuke Honma, Yoshito Hamada
-
Publication number: 20170073335Abstract: The present invention provides a compound having a particular chemical structure or a pharmacologically acceptable salt thereof which has an excellent inhibitory effect on EZH1 and/or EZH2 activity. The present invention provides a compound having a 1,3-benzodioxole structure represented by the general formula (I) or a pharmacologically acceptable salt thereof, or a pharmaceutical composition comprising the compound (wherein R1, R2, R3, R4, R5, R6, and V in the formula (I) are each as defined in the present specification).Type: ApplicationFiled: March 16, 2015Publication date: March 16, 2017Applicant: DAIICHI SANKYO COMPANY, LIMITEDInventors: Osamu KANNO, Jun WATANABE, Takao HORIUCHI, Akira NAKAO, Keisuke SUZUKI, Tomonori YAMASAKI, Nobuaki ADACHI, Daisuke HONMA, Yoshito HAMADA
-
Patent number: 9484235Abstract: In a substrate processing apparatus 1 which performs a process on a substrate W, each of multiple processing modules 2 includes at least a first processing member 21 and a second processing member 22, and substrate transfer devices 15 and 17 transfer substrates W into the multiple processing modules 2. Further, a controller 3 configured to control the substrate processing apparatus 1 stores member operating possibility information on whether it is possible to use the first processing member 21 and the second processing member 22 provided in each of the multiple processing modules 2, and the controller 3 creates, based on the member operating possibility information and process recipe information on processes to be performed on the substrates W, a transfer schedule in which the substrate transfer devices 15 and 17 transfer the substrates W into the multiple processing modules 2 in parallel.Type: GrantFiled: September 9, 2013Date of Patent: November 1, 2016Assignee: TOKYO ELECTRON LIMITEDInventors: Kouichi Itou, Masahiro Nasu, Daisuke Honma
-
Publication number: 20140093984Abstract: In a substrate processing apparatus 1 which performs a process on a substrate W, each of multiple processing modules 2 includes at least a first processing member 21 and a second processing member 22, and substrate transfer devices 15 and 17 transfer substrates W into the multiple processing modules 2. Further, a controller 3 configured to control the substrate processing apparatus 1 stores member operating possibility information on whether it is possible to use the first processing member 21 and the second processing member 22 provided in each of the multiple processing modules 2, and the controller 3 creates, based on the member operating possibility information and process recipe information on processes to be performed on the substrates W, a transfer schedule in which the substrate transfer devices 15 and 17 transfer the substrates W into the multiple processing modules 2 in parallel.Type: ApplicationFiled: September 9, 2013Publication date: April 3, 2014Applicant: TOKYO ELECTRON LIMITEDInventors: Kouichi Itou, Masahiro Nasu, Daisuke Honma
-
Patent number: 8043200Abstract: Disclosed is a method for replacing a process instrument in a processing apparatus, in which a target object is loaded by transfer mechanism into a processing unit and is subjected to a process by use of the process instrument. The method includes confirming that a process on the target object is finished in a processing unit designated as a process instrument replacement target, and providing information that a process instrument replacing operation is permitted to start. The method further includes, when a shutter of the processing unit designated as the process instrument replacement target is closed to perform a process instrument replacing operation and an operation prohibition state is thereby applied to the transfer mechanism, canceling the operation prohibition state to allow the transfer mechanism to perform a load/unload operation relative to a processing unit not designated as a process instrument replacement target.Type: GrantFiled: September 10, 2010Date of Patent: October 25, 2011Assignee: Tokyo Electron LimitedInventors: Naoyuki Tajiri, Akifumi Suzuki, Daisuke Honma
-
Publication number: 20110005052Abstract: Disclosed is a method for replacing a process instrument in a processing apparatus, in which a target object is loaded by transfer mechanism into a processing unit and is subjected to a process by use of the process instrument. The method includes confirming that a process on the target object is finished in a processing unit designated as a process instrument replacement target, and providing information that a process instrument replacing operation is permitted to start. The method further includes, when a shutter of the processing unit designated as the process instrument replacement target is closed to perform a process instrument replacing operation and an operation prohibition state is thereby applied to the transfer mechanism, canceling the operation prohibition state to allow the transfer mechanism to perform a load/unload operation relative to a processing unit not designated as a process instrument replacement target.Type: ApplicationFiled: September 10, 2010Publication date: January 13, 2011Applicant: TOKYO ELECTRON LIMITEDInventors: Naoyuki TAJIRI, Akifumi Suzuki, Daisuke Honma
-
Patent number: 7815558Abstract: Disclosed is a method for replacing a process instrument in a processing apparatus, in which a target object is loaded by a transfer mechanism into a processing unit and is subjected to a process by use of the process instrument. The method includes confirming that a process on the target object is finished in a processing unit designated as a process instrument replacement target, and providing information that a process instrument replacing operation is permitted to start. The method further includes, when a shutter of the processing unit designated as the process instrument replacement target is closed to perform a process instrument replacing operation and an operation prohibition state is thereby applied to the transfer mechanism, canceling the operation prohibition state to allow the transfer mechanism to perform a load/unload operation relative to a processing unit not designated as a process instrument replacement target.Type: GrantFiled: January 23, 2007Date of Patent: October 19, 2010Assignee: Tokyo Electron LimitedInventors: Naoyuki Tajiri, Akifumi Suzuki, Daisuke Honma
-
Publication number: 20070183774Abstract: Disclosed is a method for replacing a process instrument in a processing apparatus, in which an target object is loaded by transfer means into a processing unit and is subjected to a process by use of the process instrument. The method includes confirming that a process on the target object is finished in a processing unit designated as a process instrument replacement target, and providing information that a process instrument replacing operation is permitted to start. The method further includes, when a shutter of the processing unit designated as the process instrument replacement target is closed to perform a process instrument replacing operation and an operation prohibition state is thereby applied to the transfer means, canceling the operation prohibition state to allow the transfer means to perform a load/unload operation relative to a processing unit not designated as a process instrument replacement target.Type: ApplicationFiled: January 23, 2007Publication date: August 9, 2007Inventors: Naoyuki Tajiri, Akifumi Suzuki, Daisuke Honma
-
Publication number: 20050155094Abstract: BAC clones comprising the porcine RAG-1 gene were obtained by screening a porcine genomic DNA library. Three clones were obtained by subcloning the region comprising the RAG-1 gene from the BAC clones. Genetic maps were obtained by determining the nucleotide sequence of these clones using sequencing, and by mapping using restriction enzyme digests. Based on this information, targeting vectors that can knockout the RAG-1 gene were constructed. Using these vectors it is possible to construct swine that do not possess acquired immunity by suppressing endogenous porcine RAG-1 gene function.Type: ApplicationFiled: February 4, 2003Publication date: July 14, 2005Inventors: Hiroshi Yasue, Satoshi Watanabe, Daisuke Honma, Yohtaroh Takagaki, Hiromi Hatsuse